why choose us

First received: November 01, 2023

Clinical Trial: Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ischemic Stroke

Study Type: INTERVENTIONAL


Official Title: Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke, a Randomized Controlled Trial

Brief Summary: Along with the current clinical trial, the efficacy and safety of 180 mg loading dose of ticagrelor administered within 24 hours of first-ever large-vessel ischemic stroke compared to 300 mg clopidogrel were assessed through NIHSS, mRS, duration of hospital stay, and possible adverse effects.

Read more